← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable — 2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 2.0% below its 1-year high (as of 2026-09-17). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 8.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
MSD
MORGAN STANLEY EMERGING MARKETS DEBT FUND INC
Valuation N/A
Unknown
Price$7.17
Model IV—
P/IV—
Limited data — see page
MSIF
MSC INCOME FUND, INC.
Valuation N/A
Unknown Risk 51 · Elevated
Price$12.40
Model IV—
P/IV—
Limited data — see page
MSLE
Satellos Bioscience Inc.
Valuation N/A
Healthcare Risk 27 · Moderate
Price$9.75
Model IV—
P/IV—
Limited data — see page
MSTR
Strategy Inc
Valuation N/A
Financial Services Risk 27 · Moderate
Price$130.97
Model IV—
P/IV—
Market implies +75.8%/yr vs model +2.0% · above model
MTA
Metalla Royalty & Streaming Ltd.
Valuation N/A
Basic Materials Risk 42 · Elevated
Price$10.20
Model IV—
P/IV—
Limited data — see page
MTAL
Metals Acquisition Corp. II
Valuation N/A
Financial Services
Price$10.16
Model IV—
P/IV—
Limited data — see page
MTC
MMTEC, INC.
Valuation N/A
Technology Risk 35 · Moderate
Price$4.74
Model IV—
P/IV—
Market implies +111.7%/yr vs model +9.2% · above model
MTEK
Maris Tech Ltd.
Valuation N/A
Technology Risk 38 · Moderate
Price$1.03
Model IV—
P/IV—
Market implies +54.7%/yr vs model +2.0% · above model
MTEN
Mingteng International Corp Inc.
Valuation N/A
Industrials Risk 51 · Elevated
Price$1.02
Model IV—
P/IV—
Market implies +120.8%/yr vs model +2.0% · above model
MTH
Meritage Homes CORP
Valuation N/A
Industrials Risk 46 · Elevated
Price$65.78
Model IV—
P/IV—
Market implies +25.1%/yr vs model -10.0% · above model
MTLS
MATERIALISE NV
Valuation N/A
Technology Risk 41 · Elevated
Price$7.66
Model IV—
P/IV—
Limited data — see page
MTNB
Matinas BioPharma Holdings, Inc.
Valuation N/A
Healthcare Risk 33 · Moderate
Price$0.19
Model IV—
P/IV—
Market implies -8.9%/yr vs model +15.0% · below model
MTR
MESA ROYALTY TRUST/TX
Valuation N/A
Financial Services Risk 37 · Moderate
Price$2.47
Model IV—
P/IV—
Limited data — see page
MTSI
MACOM Technology Solutions Holdings, Inc.
Valuation N/A
Technology Risk 38 · Moderate
Price$274.90
Model IV—
P/IV—
Market implies +35.1%/yr vs model +12.4% · above model
MTUL
UBS AG
Valuation N/A
Financial Services Risk 52 · Elevated
Price$58.08
Model IV—
P/IV—
Limited data — see page
MTVA
MetaVia Inc.
Valuation N/A
Healthcare Risk 33 · Moderate
Price$1.58
Model IV—
P/IV—
Limited data — see page
MU
MICRON TECHNOLOGY INC
Valuation N/A
Technology Risk 32 · Moderate
Price$924.03
Model IV—
P/IV—
Market implies +55.4%/yr vs model +7.8% · above model
MUA
BLACKROCK MUNIASSETS FUND, INC.
Valuation N/A
Unknown
Price$9.81
Model IV—
P/IV—
Limited data — see page
MUC
BLACKROCK MUNIHOLDINGS CALIFORNIA QUALITY FUND, INC.
Valuation N/A
Unknown
Price$10.32
Model IV—
P/IV—
Limited data — see page
MUFG
MITSUBISHI UFJ FINANCIAL GROUP INC
Valuation N/A
Financial Services Risk 44 · Elevated
Price$23.89
Model IV—
P/IV—
Limited data — see page
MUJ
BLACKROCK MUNIHOLDINGS NEW JERSEY QUALITY FUND, INC.
Valuation N/A
Unknown
Price$11.89
Model IV—
P/IV—
Limited data — see page
MUX
McEwen Inc.
Valuation N/A
Basic Materials Risk 32 · Moderate
Price$18.60
Model IV—
P/IV—
Market implies +76.7%/yr vs model +7.9% · above model
MUZE
Muzero Acquisition Corp
Valuation N/A
Financial Services
Price$10.00
Model IV—
P/IV—
Limited data — see page
MUZEU
Muzero Acquisition Corp
Valuation N/A
Financial Services
Price$10.10
Model IV—
P/IV—
Limited data — see page
MUZEW
Muzero Acquisition Corp
Valuation N/A
Financial Services
Price$0.24
Model IV—
P/IV—
Limited data — see page
MVIS
MICROVISION, INC.
Valuation N/A
Technology Risk 45 · Elevated
Price$1.64
Model IV—
P/IV—
Market implies +96.9%/yr vs model +2.0% · above model
MVO
MV Oil Trust
Valuation N/A
Energy
Price$0.60
Model IV—
P/IV—
Limited data — see page
MWC
Micware Co., Ltd.
Valuation N/A
Technology Risk 51 · Elevated
Price$1.83
Model IV—
P/IV—
Limited data — see page
MWH
SOLV Energy, Inc.
Valuation N/A
Industrials Risk 50 · Elevated
Price$25.71
Model IV—
P/IV—
Limited data — see page
MX
MAGNACHIP SEMICONDUCTOR Corp
Valuation N/A
Technology Risk 27 · Moderate
Price$2.95
Model IV—
P/IV—
Market implies +19.6%/yr vs model +2.0% · above model
MXCT
MAXCYTE, INC.
Valuation N/A
Industrials Risk 32 · Moderate
Price$1.16
Model IV—
P/IV—
Market implies +30.8%/yr vs model +2.0% · above model
MXE
MEXICO EQUITY & INCOME FUND INC
Valuation N/A
Unknown
Price$13.32
Model IV—
P/IV—
Limited data — see page
MXF
MEXICO FUND INC
Valuation N/A
Unknown
Price$21.32
Model IV—
P/IV—
Limited data — see page
MXL
MAXLINEAR, INC
Valuation N/A
Technology Risk 30 · Moderate
Price$64.79
Model IV—
P/IV—
Market implies +61.2%/yr vs model +2.0% · above model
MYI
BLACKROCK MUNIYIELD QUALITY FUND III, INC.
Valuation N/A
Unknown
Price$10.33
Model IV—
P/IV—
Limited data — see page
MYN
BLACKROCK MUNIYIELD NEW YORK QUALITY FUND, INC.
Valuation N/A
Unknown
Price$9.02
Model IV—
P/IV—
Limited data — see page
MYSE
Myseum.AI, Inc.
Valuation N/A
Communication Services Risk 29 · Moderate
Price$2.67
Model IV—
P/IV—
Market implies +150.0%/yr vs model +2.0% · above model
MYSEW
Myseum.AI, Inc.
Valuation N/A
Communication Services Risk 35 · Moderate
Price$0.00
Model IV—
P/IV—
Market implies +60.0%/yr vs model +2.0% · above model
MYSZ
My Size, Inc.
Valuation N/A
Technology Risk 28 · Moderate
Price$2.32
Model IV—
P/IV—
Market implies -50.0%/yr vs model +50.0% · below model
MYX
Maywood Acquisition Corp. 2
Valuation N/A
Financial Services
Price$9.99
Model IV—
P/IV—
Limited data — see page
MYXXR
Maywood Acquisition Corp. 2
Valuation N/A
Financial Services
Price$0.21
Model IV—
P/IV—
Limited data — see page
MYXXU
Maywood Acquisition Corp. 2
Valuation N/A
Financial Services
Price$10.20
Model IV—
P/IV—
Limited data — see page
MYXXW
Maywood Acquisition Corp. 2
Valuation N/A
Financial Services
Price$0.08
Model IV—
P/IV—
Limited data — see page
MZYX
MOZAYYX Acquisition Corp.
Valuation N/A
Financial Services
Price$10.00
Model IV—
P/IV—
Limited data — see page
NA
Nano Labs Ltd
Valuation N/A
Technology Risk 42 · Elevated
Price$2.48
Model IV—
P/IV—
Market implies +25.2%/yr vs model +15.0% · above model
NAAS
NaaS Technology Inc.
Valuation N/A
Consumer Cyclical Risk 27 · Moderate
Price$3.25
Model IV—
P/IV—
Market implies +16.4%/yr vs model +15.0% · in line
NAC
Nuveen California Quality Municipal Income Fund
Valuation N/A
Unknown
Price$11.07
Model IV—
P/IV—
Limited data — see page
NAD
Nuveen Quality Municipal Income Fund
Valuation N/A
Unknown
Price$11.02
Model IV—
P/IV—
Limited data — see page
NAK
NORTHERN DYNASTY MINERALS LTD
Valuation N/A
Basic Materials Risk 51 · Elevated
Price$1.41
Model IV—
P/IV—
Limited data — see page
NAKA
Nakamoto Inc.
Valuation N/A
Financial Services Risk 27 · Moderate
Price$7.78
Model IV—
P/IV—
Market implies +125.1%/yr vs model +2.0% · above model
NAMI
Jinxin Technology Holding Co
Valuation N/A
Consumer Defensive Risk 31 · Moderate
Price$2.28
Model IV—
P/IV—
Market implies +43.0%/yr vs model +15.0% · above model
NAMM
Namib Minerals
Valuation N/A
Basic Materials Risk 27 · Moderate
Price$1.34
Model IV—
P/IV—
Limited data — see page
NAMMW
Namib Minerals
Valuation N/A
Basic Materials Risk 42 · Elevated
Price$0.20
Model IV—
P/IV—
Limited data — see page
NAMS
NewAmsterdam Pharma Co N.V.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$22.80
Model IV—
P/IV—
Market implies +69.3%/yr vs model +15.0% · above model
NAMSW
NewAmsterdam Pharma Co N.V.
Valuation N/A
Healthcare Risk 58 · Elevated
Price$11.78
Model IV—
P/IV—
Market implies +74.3%/yr vs model +2.0% · above model
NAN
NUVEEN NEW YORK QUALITY MUNICIPAL INCOME FUND
Valuation N/A
Unknown
Price$10.47
Model IV—
P/IV—
Limited data — see page
NAUT
Nautilus Biotechnology, Inc.
Valuation N/A
Healthcare Risk 30 · Moderate
Price$1.02
Model IV—
P/IV—
Limited data — see page
NAZ
NUVEEN ARIZONA QUALITY MUNICIPAL INCOME FUND
Valuation N/A
Unknown
Price$11.80
Model IV—
P/IV—
Limited data — see page
NB
NIOCORP DEVELOPMENTS LTD
Valuation N/A
Basic Materials Risk 32 · Moderate
Price$3.81
Model IV—
P/IV—
Market implies +62.4%/yr vs model +5.0% · above model
NBB
Nuveen Taxable Municipal Income Fund
Valuation N/A
Unknown
Price$15.16
Model IV—
P/IV—
Limited data — see page